ID   RMA
AC   CVCL_J385
DR   BTO; BTO:0006562
DR   CLO; CLO_0037201
DR   CCRID; 1101MOU-PUMC000414
DR   Wikidata; Q54950642
RX   PubMed=3877776;
RX   PubMed=11132152;
CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J303 ! RBL-5
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
RX   PubMed=3877776; DOI=10.1084/jem.162.6.1745;
RA   Ljunggren H.-G., Karre K.;
RT   "Host resistance directed selectively against H-2-deficient lymphoma
RT   variants. Analysis of the mechanism.";
RL   J. Exp. Med. 162:1745-1759(1985).
//
RX   PubMed=11132152; DOI=10.1007/s002510000254;
RA   Howell D., Levitt J.M., Foster P.A., Guenther M.M., Shawar S.M.,
RA   Rich R.R., Rodgers J.R.;
RT   "Heterogeneity of RMA-S cell line: derivatives of RMA-S cells lacking
RT   H2-Kb and H2-Db expression.";
RL   Immunogenetics 52:150-154(2000).
//